Healthcare & Life Sciences
CardioSignal
Finlandwww.cardiosignal.com
CardioSignal is a Healthcare & Life Sciences startup based in Finland, most recent round Series A, 3 tracked investors.
Activeseries-a
series-a
Stage
3
Investors
About CardioSignal
CardioSignal is a company headquartered in Finland. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
CardioSignal develops a CE-marked Class IIb medical device software that uses gyrocardiography to enable smartphone-based, non-invasive detection of atrial fibrillation within one minute for self-monitoring, clinical use, and population health programs.
Explore CardioSignal's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.